NCT06017895View on ClinicalTrials.gov

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

February 15, 2026

Study Completion Date

February 28, 2026

Conditions
Swallowing-induced Pain
Interventions
DRUG

doxepin solution

2.0 mL doxepin solution (5mg/mL) sprayed to the posterior pharyngeal wall

OTHER

Placebo

2.0 mL placebo sprayed to the posterior pharyngeal wall

Trial Locations (1)

510515

RECRUITING

Southern medical university, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER